Compare $FTH vs $OLMA | Chartloom

Compare

$FTH vs $OLMA

Faeth Therapeutics, Inc · Olema Pharmaceuticals Inc

FTH

Faeth Therapeutics, Inc

OLMA

Olema Pharmaceuticals Inc

Compare $FTH vs $OLMA

Comparing Faeth Therapeutics, Inc and Olema Pharmaceuticals Inc

FTHFaeth Therapeutics, Inc

OLMAOlema Pharmaceuticals Inc

FTHFaeth Therapeutics, Inc

Market cap

$671M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

79.1%

52W performance

79.1%

FCF yield

-5.0%

OLMAOlema Pharmaceuticals Inc

Market cap

$683M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-27.1%

FCF yield

-24.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FTH

OLMA

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

FTH$671M

OLMA$683M

Enterprise Value

FTH$644M

OLMA$637M

Price

FTH$26.03

OLMA$7.82

P/E Ratio

FTHN/A

OLMAN/A

P/S Ratio

FTH0.00x

OLMA0.00x

EV/Sales

FTH0.00x

OLMA0.00x

EV/EBITDA

FTH0.00x

OLMA0.00x

P/B Ratio

FTH4.08x

OLMA1.67x

P/FCF Ratio

FTHN/A

OLMAN/A

EV/FCF

FTH-19.02x

OLMA-3.86x

PEG Ratio

FTHN/A

OLMAN/A

Forward P/E (NTM)

FTHN/A

OLMAN/A

Forward P/S (NTM)

FTHN/A

OLMAN/A

Revenue (TTM)

FTH$0

OLMA$0

Revenue Growth (YoY)

FTHN/A

OLMAN/A

Forward Rev Growth

FTH77.6%

OLMA820.6%

Gross Margin (TTM)

FTH0.0%

OLMA0.0%

Operating Margin (TTM)

FTH0.0%

OLMA0.0%

EBITDA Margin (TTM)

FTH0.0%

OLMA0.0%

Net Margin (TTM)

FTH0.0%

OLMA0.0%

FCF Margin (TTM)

FTHN/A

OLMAN/A

Net Income (TTM)

FTH$-196M

OLMA$-205M

FCF (TTM)

FTH$-34M

OLMA$-165M

EPS (TTM)

FTH-$34.65

OLMA-$1.96

ROE (TTM)

FTH-18959.0%

OLMA-4822.0%

ROA (TTM)

FTH-17568.0%

OLMA-4300.0%

ROIC (TTM)

FTH-18946.0%

OLMA-4788.0%

Cash

FTH$27M

OLMA$49M

Debt

FTH$0

OLMA$3M

Net Cash/Debt

FTH$27M

OLMA$46M

Current Ratio (TTM)

FTH19.69x

OLMA8.86x

Quick Ratio (TTM)

FTH19.55x

OLMA8.75x

Debt/Equity (TTM)

FTH0.00x

OLMA0.01x

Debt/Assets (TTM)

FTH0.0%

OLMA0.0%

Interest Coverage (TTM)

FTHN/A

OLMAN/A

Net Debt/EBITDA (TTM)

FTH0.00x

OLMA0.00x

Beta

FTH2.05

OLMA1.98

52W Performance

FTH79.1%

OLMA-27.1%

YTD Performance

FTH79.1%

OLMA-69.1%

% from 52W High

FTH-38.2%

OLMA-78.4%

% from 52W Low

FTH93.8%

OLMA17.6%

Asset Turnover (TTM)

FTH0.00x

OLMA0.00x

FCF Yield (TTM)

FTH-5.0%

OLMA-24.1%

Earnings Yield (TTM)

FTH-29.1%

OLMA-29.9%

Dividend Yield (TTM)

FTHN/A

OLMAN/A

Rule of 40

FTH0.0

OLMA0.0

EV/GP/RG

FTHN/A

OLMAN/A

Ticker research

View FTH research View OLMA research

Metric	FTH Faeth Therapeutics, Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$671M	$683M
Enterprise Value	$644M	$637M
Price	$26.03	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.08x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.02x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	77.6%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-196M	$-205M
FCF (TTM)	$-34M	$-165M
EPS (TTM)	-$34.65	-$1.96
ROE (TTM)	-18959.0%	-4822.0%
ROA (TTM)	-17568.0%	-4300.0%
ROIC (TTM)	-18946.0%	-4788.0%
Financial Health
Cash	$27M	$49M
Debt	$0	$3M
Net Cash/Debt	$27M	$46M
Current Ratio (TTM)	19.69x	8.86x
Quick Ratio (TTM)	19.55x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	1.98
52W Performance	79.1%	-27.1%
YTD Performance	79.1%	-69.1%
% from 52W High	-38.2%	-78.4%
% from 52W Low	93.8%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.0%	-24.1%
Earnings Yield (TTM)	-29.1%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FTH research	View OLMA research

Valuation

P/S Ratio

FTH

0.00x

OLMA

0.00x

EV/FCF

FTH

-19.02x

OLMA

-3.86x

Growth & revenue

Forward Revenue Growth

OLMA

820.6%

FTH

77.6%

Profitability & performance

Gross Margin

FTH

0.0%

OLMA

0.0%

ROE

OLMA

-4822.0%

FTH

-18959.0%

FCF Yield %

FTH

-5.0%

OLMA

-24.1%

52-Week Performance

FTH

79.1%

OLMA

-27.1%

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

FTH$671M

OLMA$683M

Enterprise Value

FTH$644M

OLMA$637M

Price

FTH$26.03

OLMA$7.82

P/E Ratio

FTHN/A

OLMAN/A

P/S Ratio

FTH0.00x

OLMA0.00x

EV/Sales

FTH0.00x

OLMA0.00x

EV/EBITDA

FTH0.00x

OLMA0.00x

P/B Ratio

FTH4.08x

OLMA1.67x

P/FCF Ratio

FTHN/A

OLMAN/A

EV/FCF

FTH-19.02x

OLMA-3.86x

PEG Ratio

FTHN/A

OLMAN/A

Forward P/E (NTM)

FTHN/A

OLMAN/A

Forward P/S (NTM)

FTHN/A

OLMAN/A

Revenue (TTM)

FTH$0

OLMA$0

Revenue Growth (YoY)

FTHN/A

OLMAN/A

Forward Rev Growth

FTH77.6%

OLMA820.6%

Gross Margin (TTM)

FTH0.0%

OLMA0.0%

Operating Margin (TTM)

FTH0.0%

OLMA0.0%

EBITDA Margin (TTM)

FTH0.0%

OLMA0.0%

Net Margin (TTM)

FTH0.0%

OLMA0.0%

FCF Margin (TTM)

FTHN/A

OLMAN/A

Net Income (TTM)

FTH$-196M

OLMA$-205M

FCF (TTM)

FTH$-34M

OLMA$-165M

EPS (TTM)

FTH-$34.65

OLMA-$1.96

ROE (TTM)

FTH-18959.0%

OLMA-4822.0%

ROA (TTM)

FTH-17568.0%

OLMA-4300.0%

ROIC (TTM)

FTH-18946.0%

OLMA-4788.0%

Cash

FTH$27M

OLMA$49M

Debt

FTH$0

OLMA$3M

Net Cash/Debt

FTH$27M

OLMA$46M

Current Ratio (TTM)

FTH19.69x

OLMA8.86x

Quick Ratio (TTM)

FTH19.55x

OLMA8.75x

Debt/Equity (TTM)

FTH0.00x

OLMA0.01x

Debt/Assets (TTM)

FTH0.0%

OLMA0.0%

Interest Coverage (TTM)

FTHN/A

OLMAN/A

Net Debt/EBITDA (TTM)

FTH0.00x

OLMA0.00x

Beta

FTH2.05

OLMA1.98

52W Performance

FTH79.1%

OLMA-27.1%

YTD Performance

FTH79.1%

OLMA-69.1%

% from 52W High

FTH-38.2%

OLMA-78.4%

% from 52W Low

FTH93.8%

OLMA17.6%

Asset Turnover (TTM)

FTH0.00x

OLMA0.00x

FCF Yield (TTM)

FTH-5.0%

OLMA-24.1%

Earnings Yield (TTM)

FTH-29.1%

OLMA-29.9%

Dividend Yield (TTM)

FTHN/A

OLMAN/A

Rule of 40

FTH0.0

OLMA0.0

EV/GP/RG

FTHN/A

OLMAN/A

Ticker research

View FTH research View OLMA research

Metric	FTH Faeth Therapeutics, Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$671M	$683M
Enterprise Value	$644M	$637M
Price	$26.03	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.08x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.02x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	77.6%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-196M	$-205M
FCF (TTM)	$-34M	$-165M
EPS (TTM)	-$34.65	-$1.96
ROE (TTM)	-18959.0%	-4822.0%
ROA (TTM)	-17568.0%	-4300.0%
ROIC (TTM)	-18946.0%	-4788.0%
Financial Health
Cash	$27M	$49M
Debt	$0	$3M
Net Cash/Debt	$27M	$46M
Current Ratio (TTM)	19.69x	8.86x
Quick Ratio (TTM)	19.55x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	1.98
52W Performance	79.1%	-27.1%
YTD Performance	79.1%	-69.1%
% from 52W High	-38.2%	-78.4%
% from 52W Low	93.8%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.0%	-24.1%
Earnings Yield (TTM)	-29.1%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FTH research	View OLMA research